Category Archives: News and Events

BriaCell to Present at a Breast Cancer Symposium, and Enters into a Research Agreement with Terasaki Foundation Laboratory
December 5, 2016

Berkeley, CA and Vancouver, BC – December 5, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Files a Patent Application for its Companion Diagnostic Platform to complement BriaVax™
November 29, 2016

Berkeley, CA and Vancouver, BC – November 29, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Provides Clinical Development Update on BriaVax™
November 10, 2016

Berkeley, CA and Vancouver, BC – November 10, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces the Appointment of Biotechnology Veteran William Williams as New CEO and Director
October 26, 2016

Berkeley, CA and Vancouver, BC – October 26, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BioNap Consulting’s Jason Napodano Issues an Update on BriaCell Therapeutics Corp.
September 27, 2016

Berkeley, CA and Vancouver, BC–(Marketwired – September 27, 2016) – BioNap Consulting, Inc.’s Senior Equity ...

BriaCell Appoints New York-Based RK Equity Advisors and TrueNorth LifeScience a Corporate Advisor
September 15, 2016

Berkeley, CA and Vancouver, BC – September 15, 2016 – BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Closes Oversubscribed Non-Brokered Private Placement
August 19, 2016

BERKELEY, CALIFORNIA and VANCOUVER, BRITISH COLUMBIA–(Marketwired – Aug. 19, 2016) – BriaCell Therapeutics Corp. (“BriaCell” ...

BriaCell Appoints the Lead Principal Investigator and First Clinical Site for its Upcoming Phase I/IIa Clinical Trial in Advanced Breast Cancer
August 17, 2016

– Dr. Jarrod P. Holmes, a prominent breast cancer vaccine expert to lead the study ...

BriaCell Announces Non-Brokered Private Placement
August 12, 2016

BriaCell Therapeutics Corp. (OTCQB:BCTXF)(TSX VENTURE:BCT) (“BriaCell”, the “Company”, or “BCT”) announced today that it intends ...

BriaCell Appoints Contract Research Organization, Cancer Insight, to Manage its Upcoming Phase I/IIa Clinical Trials in Advanced Breast Cancer
May 18, 2016

BERKELEY, CA and VANCOUVER, BC–(Marketwired – May 18, 2016) – BriaCell Therapeutics Corp. (“BriaCell” or ...

Skip to content